Tag: TSLA

Blue Horseshoe Stocks: Fresh News Plays & More

Fresh News Plays

We’ve got a couple of stocks that we’ve been tracking this summer coming out with noteworthy press in the early hours this morning, we’re going to want to increase our alertness level for each of them as we kick off a new trading week.

NuGene International, Inc. NUGN –  NUGN is appearing in the news feed with a substantial revelation at an opportune time this morning. The stock took an absolute beating last week, and just began to find its footing off of a previous support level on Friday. At the moment the stock is extremely oversold. Coupling that with the addition of this morning’s PR announcing the company’s Q2 revenue growth of more than 150% over the prior year, conditions could be just right for a rebound. We’ll be on a sharp lookout for that possibility.

___

AVEO Pharmaceuticals, Inc. AVEO

AVEO stock is gapping up immensely in premarket trading on the strength of a deal the company just announced with Novartis. The potential for both a momentum play and/or a bounce play is elevated. We’ll need to see it maintain support at or above 2.20 (a previous resistance point) on any pullbacks to remain interested. With high profile news like this, it’s quite possible that it will do so.

AVEO Oncology (AVEO) today announced an exclusive, worldwide license agreement with Novartis for the development and commercialization of AVEO’s first-in-class, potent, humanized inhibitory antibody targeting growth differentiation factor 15 (GDF15), AV-380, and related antibodies>>>Full PR

Tesla Motors, Inc. TSLA – Options Idea

We’d like to submit a potential options trading idea to start the week. Morgan Stanley has raised their price target on the stock (Currently valued in the mid-$250’s) from $280 to $465, and TSLA is gapping up on the heels of that announcement. As a result, we see the potential for some intraday and/or intraweek trading opportunities in the range of TSLA Weekly $250-265 Calls.

Extended Watchlist:
ZU(Gapping Up), SFXE & XGTI(Both Oversold, on Bottom Watch)

Blue Horseshoe Stocks: Options, Bottom-Plays & More

OncoNova Therapeutics, Inc. ONTX

ONTX is hitting the scanner as a premarket gapper this morning, on the heels of a PR announcing a “pivotal” Phase III drug trial. (>>View PR)

The stock’s 1-year analyst price target of $5 doesn’t seem all that far-fetched, especially if ONTX can break past resistance in the channel between 3.00-3.25 as we’ve outlined on the following chart snapshot. Also looking ripe are the RSI which is creeping toward the 50-line, and the MACD in the midst of bullish cross.

We’ll continue to keep an eye on the stock today and into next week.

Tesla Motors, Inc. TSLA – Options Idea

To carry on our recent tradition of presenting weekly options ideas on Friday (which has yielded us some truly epic gains), we have TSLA. Remember, trading weekly contracts so close to expiration carries added risk, so we always need to exercise extra caution when doing so.

The stock is responding well to news that the company’s share offering would be increased to nearly 2.7M shares, or $642.5M. As a result of this increased activity, we’ve identified the range in which the heaviest action is likely to occur in the event of a sustained uptrend.

Our main target area will be TSLA Weekly $242.50-247.50 Calls. We’ll of course begin with the lowest strike price, which is currently in the money, and roll it up from there as needed, depending on how the day’s trading activity unfolds.

Potential Bottom-Play

Pacific Sunwear of California, Inc. PSUN – We also want to quickly make mention of PSUN, which we’ve noticed has come down to new 52-week lows. As our regulars our well aware by now, these sorts of plays have been an area of extreme success lately. Just take a look at the chart to see what we mean. This is a stock that is sorely due for a rebound, and we intend to be watching closely for when that occurs.

Extended Watchlist:
PBMD, AREN, FIT

Blue Horseshoe Stocks: TSLA Options Recap & More

Tesla Motors, Inc. TSLA – Options

Despite another choppy day for the markets as a whole, we were able to find a diamond in the rough with our TSLA Options Idea in Thursday’s premarket report.

As the stock was gapping up, we identified the possibility of some dip-and-rip scenarios occurring in weekly TSLA $275-280 Calls and that’s precisely what we got. There was some extremely impressive action with the $275’s and $277.50’s in particular, that could’ve provided traders with exponential gains.

The $275 Calls jumped out of the starting gate and went on an initial run from 5.00 to 7.60 (+52%) in the first couple minutes of the session. The dip-and-rip we were after provided an even bigger opportunity as the contracts reached a midday low of .78 before rebounding, and absolutely exploded back to a 5.10 close. That marked a second intraday rip of 554%

The $277.50’s traded in a similar pattern; the initial move was from 3.20 to 5.40 (+69%), and their dip took them to a low of .21 before re-launching as high as 3.00 into the close. That was a mind-boggling 1329% rip.

NuGene International, Inc. NUGN

NUGN has been an ongoing point of interest for us over the past few weeks; we alerted the stock in the third week of June, and at that time, observed a 2.67 swing-low. Since then, the chart has been on a steady incline, surging as much as 47% as it hit a high of 3.88 on both Wednesday and Thursday.

We’ll be looking for the possibility of the stock cracking through that resistance to continue its uptrend into this week.

There’s a fresh PR coming off of the wire this morning as well:

IRVINE, Calif., July 6, 2015 /PRNewswire/ — NuGene International, Inc. (“NuGene”) (NUGN), a developer, manufacturer and marketer of advanced skin and hair care lines utilizing adipose derived human stem cells and stem cell media, conducted one-on-one meetings with top beauty editors in New York City including Allure, Vogue, Glamour, Marie Claire, Self, Shape, More, Town and Country, People, People Style Watch, Cosmopolitan, Better Homes and Gardens and W. >> View PR

Extended Watchlist:
PVSP, WTW, ONCY, JDST, CLSN, ASTI, ENZN

Blue Horseshoe Stocks: Wrapping Up the Short Week

American Green, Inc. ERBB

As we prepare to adjourn for the long holiday weekend, we want to circle back to an alert we issued on Monday regarding ERBB’s status as a potential bottom-bounce play. The resulting action fit neatly into that category, and all in all the stock went on to log solid move for the week.

It began with an initial dip to .0037 Monday, where the rebound began to occur. Yesterday the stock registered a high of .0045; that hashes out to a solid three-session swing of 22%

With the stock closing at .0042 yesterday, maintaining a good portion of its advances, we’ll want to keep a spot reserved on our watchlist for ERBB. We’ll look for it to continue registering higher highs and higher lows, and maintain support at the .0037-.004 range, eventually breaking back above resistance at .005.

Pervasip Corp. PVSP

PVSP is an old favorite favorite of ours; we tracked it over more than a thousand-percent gain early this year, as well as a nice 66% intraweek swing at the time of our last mention in the 1st week of June. The stock has been heating up again this week, with the PPS cracking above the 50DMA (.0014) yesterday, and managing a strong close one tick above at its high of day at .0015.

We’re going to look for the stock to make a strong finish to this short week, and keep our ears to the tracks for the forthcoming acquisition update promised in Monday’s letter to shareholders.  Apparently PVSP is putting the finishing touches on obtaining “a revenue-producing retail distribution company servicing the hydroponic and indoor grow facility market in Denver, Colorado.“ so we’ll be keen to receive further information on that when it becomes available.

Definitive Rest Mattress Co. DRMC

We wanted to recap the action on DRMC following its appearance in yesterday’s morning report. The stock executed a dip-and-rip pattern around midday that carried it over a range from .0027-.0035; an intraday move of +30%  This occurred on almost 3x the monthly average volume, but in and of itself the volume was still relatively light. A pickup in buying pressure could really send DRMC for a ride, so we’ll keep watch for that, and for the stock to continue maintaining support above the 50DMA.

SPY Options Update

On Tuesday, we formulated an idea for trading SPY options on the heels of some market pressure caused by the uncertainty surrounding the current situation in Greece. We would look at 205.50-207 Puts and Calls until a trend was firmly established, and then determine our course of action. When the SPY found support above the 200DMA and began to rebound, that’s when we were able to identify the Call-side as the way to play, and the bulk of the action came in the $207’s during yesterday’s session.

There were multiple swings of significant magnitude which provided potential gains. First, from .90-1.26 (40%), followed by another from .75-1.00 (33%), and a third which ranged from .66-1.05 (59%). That worked out to a cumulative total of 132%  for the day.

Extended Watchlist:
HNSN, PVCT, BLDP, NAVB, TSLA($275-280 Calls, watch for dip-and-rip)

Blue Horseshoe Stocks: ACRX, DSCO & More

Tesla Motors, Inc. TSLA – Options

Yesterday, those of our readers following our recent coverage of TSLA were once again presented with opportunities coming out of the 05/22 $230-240 Calls that we’ve been monitoring since Friday. TSLA registered a higher high and a higher low for the fifth consecutive session, topping out at 248.30. As a result, the total possible gains on our initial calls were pushed even further into the green, so we wanted to provide an update on those figures:

$230 Calls  – Friday’s Low: 6.85 – Yesterday’s High: 17.95 – Max Gain: 162%

$232.50 Calls  – Friday’s Low: 5.32 – Yesterday’s High: 16.90 – Max Gain: 217%

$235 Calls  – Friday’s Low: 5.96 – Yesterday’s High: 13.95 – Max Gain: 134%

$237.50 Calls  – Friday’s Low: 3.16 – Yesterday’s High: 12.00  – Max Gain: 280%

$240 Calls  – Friday’s Low: 3.84 – Yesterday’s High: 10.50 – Max Gain: 173%

These moves are a perfect example of what draws us to options trading; with just a 6% increase in TSLA stock, we’ve witnessed huge gains across the board in the options chain. These contracts don’t expire until next Friday, so we’ll keep our fingers on TSLA’s pulse until that time.

AcelRx Pharmaceuticals, Inc. ACRX

Popping up on our scanner this morning is a play that has both an interesting chart as well as a blockbuster PR out today that is leading to a gap-up in premarket trading (3.30-3.80’s).

We’re catching the stock as it comes up off of a relative bottom, and as we point out on the snapshot below, there are several attractive features of the current ACRX chart.

Couple that with this morning’s revelation of a contract the company has struck with the US Dept. of Defense, and ACRX becomes instantly worthy of our attention as the week draws to a close.

Discovery Laboratories, Inc. DSCO

Speaking of pharma stocks with fresh news, DCSO is also cropping up on our scanner this morning. Like the aforementioned play, this morning/s PR is resulting in a gap-up, and we’ll want to have our eyes peeled for potential advantageous activity on the chart once the session commences.

According to the release, Phase II testing of its AEROSURF® product has yielded “encouraging safety and physiological data suggest that aerosolized KL4 surfactant can be delivered to the lung of premature infants with respiratory distress syndrome”

Extended Watchlist:
PTBI, CYRN, BAA, CDTI, WOGI

Get Our FREE Daily Reports!

SUBSCRIBE